From: Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
Controls | CKD | P-value | P-value | |
---|---|---|---|---|
N = 19 | N = 23 | Adjusted for age | ||
Maximal MFI TRAP, AU (IQR) | 11.4 (9.2-12.2) | 9.7 (7.9-10.8) | 0.032 | 0.095 |
Maximal MFI ADP, AU (IQR) | 2.6 (1.9-3.5) | 1.6 (1.2-2.1) | 0.002 | 0.004 |
Maximal MFICRP, AU (IQR) | 11.5 (9.5-12.9) | 9.2 (8.5-10.8) | 0.004 | 0.010 |
EC50 TRAP, μM (IQR) | 1.9 (1.5-2.5) | 2.3 (1.8-2.6) | 0.372 | 0.182 |
EC50 ADP, μM (IQR) | 0.9 (0.6-1.1) | 0.89 (0.7-1.1) | 0.544 | 0.597 |
EC50 CRP, ng/ml (IQR) | 120 (46.7-312.7) | 116.1 (46.1-270.5) | 0.955 | 0.660 |
AUC TRAP, AU (IQR) | 47.1 (41.1-54.2) | 39.5 (32.9-44.4) | 0.012 | 0.023 |
AUC ADP, AU (IQR) | 8.9 (7.9-12.2) | 5.8 (3.8-7.3) | 0.002 | 0.003 |
AUC CRP, AU (IQR) | 30.3 (22.1-41.9) | 23.4 (18.9-34.7) | 0.063 | 0.322 |